Last reviewed · How we verify

ARTISS human fibrin sealant — Competitive Intelligence Brief

ARTISS human fibrin sealant (ARTISS human fibrin sealant) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hemostatic agent. Area: Surgical and Trauma.

phase 2 Hemostatic agent Surgical and Trauma Biologic Live · refreshed every 30 min

Target snapshot

ARTISS human fibrin sealant (ARTISS human fibrin sealant) — DeNova Research. ARTISS human fibrin sealant works by promoting hemostasis through the formation of a fibrin clot.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ARTISS human fibrin sealant TARGET ARTISS human fibrin sealant DeNova Research phase 2 Hemostatic agent
Thrombin JMI Thrombin JMI University of Kansas Medical Center marketed Topical hemostatic agent Fibrinogen
chitosan gel chitosan gel Ain Shams University marketed Biopolymer wound dressing / hemostatic agent
Blood Stopper (Ankaferd) Blood Stopper (Ankaferd) Ankara Ataturk Sanatorium Training and Research Hospital marketed Topical hemostatic agent
Bovine thrombin Bovine thrombin Instituto Grifols, S.A. marketed Coagulation factor / Hemostatic agent Fibrinogen
Haemostatic solution "Haemoblock" application Haemostatic solution "Haemoblock" application Ryazan State Medical University marketed Topical hemostatic agent
rFVIIa, rFVIIa + TXA rFVIIa, rFVIIa + TXA Oslo University Hospital marketed Hemostatic agents Extrinsic coagulation pathway and fibrinolysis inhibition

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hemostatic agent class)

  1. Chang Gung Memorial Hospital · 1 drug in this class
  2. DeNova Research · 1 drug in this class
  3. Ethicon, Inc. · 1 drug in this class
  4. Mallinckrodt · 1 drug in this class
  5. Sun Yat-sen University · 1 drug in this class
  6. Swiss Cancer Institute · 1 drug in this class
  7. Takeda · 1 drug in this class
  8. WakeMed Health and Hospitals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ARTISS human fibrin sealant — Competitive Intelligence Brief. https://druglandscape.com/ci/artiss-human-fibrin-sealant. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: